New Arthritis Drug Arava Website Launched by Pennsylvania Personal Injury Law Firm Anapol Schwartz

The Pennsylvania personal injury law firm of Anapol Weiss is pleased to announce the debut of its new Arava website: The new website provides valuable information and resources regarding the following:

  • Arava Side Effects
  • Liver Failure Risks
  • FDA Black Box Warnings
  • Liver Failure Wrongful Death
  • Disease-Modifying Antirheumatic Drugs (DMARDs)
  • Arava Lawsuits

The arthritis drug Arava (leflunomide) is manufactured by drug maker Sanofi-Aventis and was approved by the Food and Drug Administration (FDA) in 1998 for those afflicted with rheumatoid arthritis. However, after reviewing Arava side effects from 2002 to 2009, the FDA identified a connection between the arthritis drug and 14 liver failure deaths and at least 49 cases of severe liver injury.

The new Arava website includes information regarding the drug safety alert that was issued by the FDA on July 13, 2010 informing patients and medical professionals of Arava’s black box warning. Aside from the risk of Arava liver failure, other potential side effects of Arava described in more detail on the new website include jaundice, joint disorder, encephalopathy (brain disease), blistering on the inside of eyelids, nose or mouth, coagulopathy (blood clotting problems), joint disorders, chest pain, peeling or blistering skin, and others.

To access more information regarding the revised Arava warning as well as other pertinent updates on the arthritis drug, please visit The website managed by the experienced Arava side effects lawyers at Anapol Weiss also provides additional information to help those afflicted by Arava in determining whether they have a potential Arava side effects lawsuit.

Contact Information